Transgene Biotek Ltd

Transgene Biotek Ltd

₹ 7.55 3.42%
24 Apr - close price
About

Incorporated in 1990, Transgene Biotek Limited is in the business of Research & Development of Pharmaceutical products. The registered office of the company is in Telangana.[1]

Key Points

Business Expertise:[1]
Company is in production and oral formulation of different proteins using TrabiORAL technology
a) Oncology[2]
b) Auto Immunity[3]
c) Drug Delivery[4]
d) Biogenerics[5]

  • Market Cap 57.2 Cr.
  • Current Price 7.55
  • High / Low 12.5 / 2.45
  • Stock P/E
  • Book Value -0.86
  • Dividend Yield 0.00 %
  • ROCE -57.6 %
  • ROE %
  • Face Value 10.0

Pros

Cons

  • Company has low interest coverage ratio.
  • Promoter holding is low: 23.6%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Miscellaneous

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
0.16 0.01 0.00 0.00 0.00 0.09 0.06 0.00 0.00 0.00 0.10 0.05 0.05
0.18 0.20 0.12 0.11 0.15 0.14 0.20 0.52 0.13 0.22 0.22 0.17 0.16
Operating Profit -0.02 -0.19 -0.12 -0.11 -0.15 -0.05 -0.14 -0.52 -0.13 -0.22 -0.12 -0.12 -0.11
OPM % -12.50% -1,900.00% -55.56% -233.33% -120.00% -240.00% -220.00%
0.05 0.13 0.04 0.04 0.04 0.08 0.04 0.04 0.04 0.04 0.04 0.04 0.04
Interest 0.07 0.07 0.06 0.06 0.06 0.06 0.05 0.05 0.05 0.05 0.03 0.03 0.03
Depreciation 2.48 2.48 2.47 2.47 2.47 2.51 1.24 1.24 1.24 1.24 0.02 0.02 0.02
Profit before tax -2.52 -2.61 -2.61 -2.60 -2.64 -2.54 -1.39 -1.77 -1.38 -1.47 -0.13 -0.13 -0.12
Tax % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
-2.52 -2.61 -2.61 -2.60 -2.64 -2.54 -1.39 -1.77 -1.38 -1.47 -0.13 -0.13 -0.12
EPS in Rs -0.33 -0.34 -0.34 -0.34 -0.35 -0.34 -0.18 -0.23 -0.18 -0.19 -0.02 -0.02 -0.02
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
26.24 15.01 0.97 0.30 0.18 0.28 0.12 0.07 0.00 0.17 0.09 0.06 0.20
25.06 15.78 2.79 1.81 1.32 2.84 5.12 0.75 0.87 0.70 0.55 0.68 0.77
Operating Profit 1.18 -0.77 -1.82 -1.51 -1.14 -2.56 -5.00 -0.68 -0.87 -0.53 -0.46 -0.62 -0.57
OPM % 4.50% -5.13% -187.63% -503.33% -633.33% -914.29% -4,166.67% -971.43% -311.76% -511.11% -1,033.33% -285.00%
17.07 0.00 -114.37 0.01 0.17 0.66 10.27 2.04 0.18 0.27 0.21 0.18 0.16
Interest 0.62 0.20 0.00 0.36 0.07 0.43 1.03 0.26 0.38 0.27 0.23 0.62 0.14
Depreciation 0.38 1.02 17.22 17.18 20.50 17.53 9.89 9.89 9.90 9.91 9.92 4.95 1.30
Profit before tax 17.25 -1.99 -133.41 -19.04 -21.54 -19.86 -5.65 -8.79 -10.97 -10.44 -10.40 -6.01 -1.85
Tax % 32.46% 0.00% 0.00% 0.00% 0.00% 0.00% -13.98% 0.00% 0.00% 0.00% 0.00% 0.00%
11.65 -1.99 -133.40 -19.04 -21.54 -19.86 -6.44 -8.79 -10.96 -10.43 -10.40 -6.01 -1.85
EPS in Rs 1.77 -0.30 -17.61 -2.51 -2.84 -2.62 -0.85 -1.16 -1.45 -1.38 -1.37 -0.79 -0.25
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: -42%
5 Years: -13%
3 Years: %
TTM: 33%
Compounded Profit Growth
10 Years: %
5 Years: 6%
3 Years: 13%
TTM: 74%
Stock Price CAGR
10 Years: 5%
5 Years: 10%
3 Years: 16%
1 Year: 206%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity Capital 65.77 65.77 75.77 75.77 75.77 75.77 75.77 75.77 75.77 75.77 75.77 75.77
Reserves 245.18 256.27 121.41 102.38 78.89 -34.48 -40.92 -49.71 -60.67 -71.11 -75.97 -81.98
20.76 22.46 13.06 14.34 15.28 16.01 9.84 9.14 10.33 11.33 12.02 13.12
34.02 24.14 139.21 137.84 123.15 30.88 31.97 31.45 31.43 31.01 25.40 25.57
Total Liabilities 365.73 368.64 349.45 330.33 293.09 88.18 76.66 66.65 56.86 47.00 37.22 32.48
106.82 197.80 180.58 163.40 140.95 61.16 50.97 41.10 31.20 21.32 11.40 6.45
CWIP 0.23 0.29 0.29 0.29 0.29 2.04 1.87 1.87 1.87 1.87 1.87 1.87
Investments 0.00 92.20 92.20 92.20 92.20 0.00 0.00 0.00 0.00 0.01 0.11 0.11
258.68 78.35 76.38 74.44 59.65 24.98 23.82 23.68 23.79 23.80 23.84 24.05
Total Assets 365.73 368.64 349.45 330.33 293.09 88.18 76.66 66.65 56.86 47.00 37.22 32.48

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
25.34 99.62 -2.11 -0.95 0.02 0.02 -0.63 -1.74 0.14 0.01 0.10 0.00
-144.15 -101.06 1.46 -0.02 -0.02 0.00 3.05 1.74 0.00 -0.04 -0.10 -0.01
82.72 1.50 0.60 0.94 0.00 0.00 -2.37 0.00 -0.20 0.00 0.00 0.00
Net Cash Flow -36.09 0.06 -0.05 -0.02 0.00 0.02 0.05 0.00 -0.06 -0.02 0.00 -0.01

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 394.77 448.16 6,867.27 19,941.17 3,305.28 13.04 0.00 0.00 0.00 0.00 0.00
Inventory Days 12.92 6.40 106.46 365.00 365.00 1,460.00 121.67 156.43
Days Payable 441.40 437.74 25,975.83 5,018.75 3,528.33 13,870.00 1,460.00 1,199.29
Cash Conversion Cycle -33.72 16.82 -19,002.11 19,941.17 3,305.28 13.04 -4,653.75 -3,163.33 -1,338.33 0.00 -1,042.86
Working Capital Days 1,167.75 53.01 692.37 1,533.00 2,331.94 -1,733.75 -21,413.33 -35,717.86 -14,277.94 -4,785.56 -7,908.33
ROCE % 6.44% -0.51% -6.58% -9.27% -11.85% -17.10% -14.75% -25.79% -34.93% -49.11% -73.14% -57.55%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
23.64% 23.64% 23.64% 23.64% 23.64% 23.64% 23.64% 23.64% 23.64% 23.64% 23.64% 23.64%
76.36% 76.36% 76.36% 76.36% 76.36% 76.37% 76.36% 76.36% 76.37% 76.37% 76.36% 76.36%
No. of Shareholders 10,76910,79311,13011,31711,33111,30311,43211,37111,34211,36012,22012,426

Documents